BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7371038)

  • 1. Failure of the antioxidant vitamin E to protect against adriamycin-induced cardiotoxicity in the rabbit.
    Breed JG; Zimmerman AN; Dormans JA; Pinedo HM
    Cancer Res; 1980 Jun; 40(6):2033-8. PubMed ID: 7371038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of vitamin E and selenium protection against chronic adriamycin toxicity in rabbits.
    Van Vleet JF; Ferrans VJ
    Cancer Treat Rep; 1980; 64(2-3):315-7. PubMed ID: 7407765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac disease induced by chronic adriamycin administration in dogs and an evaluation of vitamin E and selenium as cardioprotectants.
    Van Vleet JF; Ferrans VJ; Weirich WE
    Am J Pathol; 1980 Apr; 99(1):13-42. PubMed ID: 7361854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of selenium-vitamin E on adriamycin-induced cardiomyopathy in rabbits.
    Van Vleet JF; Greenwood L; Ferrans VJ; Rebar AH
    Am J Vet Res; 1978 Jun; 39(6):997-1010. PubMed ID: 666098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute adriamycin cardiotoxicity: morphologic alterations in isolated perfused rabbit heart.
    Taylor AL; Bulkley BH
    Lab Invest; 1982 Nov; 47(5):459-64. PubMed ID: 7132289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrocardiographic and biochemical evidence for the cardioprotective effect of vitamin E in doxorubicin-induced acute cardiotoxicity in rats.
    Puri A; Maulik SK; Ray R; Bhatnagar V
    Eur J Pediatr Surg; 2005 Dec; 15(6):387-91. PubMed ID: 16418954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of vitamin E on toxicity and antitumor activity of adriamycin in mice.
    Tanigawa N; Katoh H; Kan N; Mizuno Y; Tanimura H; Satomura K; Hikasa Y
    Jpn J Cancer Res; 1986 Dec; 77(12):1249-55. PubMed ID: 3102429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adriamycin cardiotoxicity amelioration by alpha-tocopherol.
    Krivit W
    Am J Pediatr Hematol Oncol; 1979; 1(2):151-3. PubMed ID: 543510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of vitamin E against adriamycin-induced toxicity in rabbits.
    Wang YM; Madanat FF; Kimball JC; Gleiser CA; Ali MK; Kaufman MW; van Eys J
    Cancer Res; 1980 Apr; 40(4):1022-7. PubMed ID: 7357532
    [No Abstract]   [Full Text] [Related]  

  • 10. Experimental animal models of adriamycin cardiotoxicity.
    Doroshow JH; Locker GY; Myers CE
    Cancer Treat Rep; 1979 May; 63(5):855-60. PubMed ID: 110445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silymarin prevents adriamycin-induced cardiotoxicity and nephrotoxicity in rats.
    El-Shitany NA; El-Haggar S; El-desoky K
    Food Chem Toxicol; 2008 Jul; 46(7):2422-8. PubMed ID: 18487002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of alpha-tocopherol on the cardiotoxicity of adriamycin in the rat.
    Sonneveld P
    Cancer Treat Rep; 1978 Jul; 62(7):1033-6. PubMed ID: 278640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of the cardiotoxicity of doxorubicin in rabbits and dogs by encapsulation in long-circulating, pegylated liposomes.
    Working PK; Newman MS; Sullivan T; Yarrington J
    J Pharmacol Exp Ther; 1999 May; 289(2):1128-33. PubMed ID: 10215696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of doxorubicin chronic toxicity in metallothionein-overexpressing transgenic mouse heart.
    Sun X; Zhou Z; Kang YJ
    Cancer Res; 2001 Apr; 61(8):3382-7. PubMed ID: 11309296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of d,l-alpha-tocopherol (vitamin E) against cardiotoxicity induced by doxorubicin and doxorubicin with cyclophosphamide in mice.
    Bjelogrlic SK; Radic J; Jovic V; Radulovic S
    Basic Clin Pharmacol Toxicol; 2005 Nov; 97(5):311-9. PubMed ID: 16236144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of vitamin A administration on resistance of rat heart against doxorubicin-induced cardiotoxicity and lethality.
    Tesoriere L; Ciaccio M; Valenza M; Bongiorno A; Maresi E; Albiero R; Livrea MA
    J Pharmacol Exp Ther; 1994 Apr; 269(1):430-6. PubMed ID: 8169849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of mitoxantrone treatment in beagle dogs previously treated with minimally cardiotoxic doses of doxorubicin.
    Tham P; Dougherty W; Iatropoulos MJ; Gordon G; James VC; Hall C; Noble JF
    Am J Pathol; 1987 Jul; 128(1):121-30. PubMed ID: 3605309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of fullerenol C60(OH)24 against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats with colorectal cancer.
    Injac R; Perse M; Cerne M; Potocnik N; Radic N; Govedarica B; Djordjevic A; Cerar A; Strukelj B
    Biomaterials; 2009 Feb; 30(6):1184-96. PubMed ID: 19046599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of ouabain on adriamycin-induced cardiovascular anomalies in chick embryos.
    Takagi Y; Bruyere HJ; Nishikawa T
    Teratology; 1989 Jun; 39(6):573-80. PubMed ID: 2772843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined cardiotoxicity of adriamycin and x-radiation.
    Fajardo LF; Eltringham JR; Steward JR
    Lab Invest; 1976 Jan; 34(1):86-96. PubMed ID: 1246126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.